-+ 0.00%
-+ 0.00%
-+ 0.00%

Wave Life Sciences Seeks Stockholders, Singapore High Court Approvals To Redomicile From Singapore To U.S.

Benzinga·04/21/2026 20:02:50
Listen to the news

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, is seeking shareholders' and Singapore High Court approvals in relation to a scheme of arrangement under Section 210 of the Companies Act 1967 of Singapore (the "Scheme of Arrangement"), in order to redomicile the parent company of the Wave Life Sciences group of companies from Singapore to the United States (the "Redomiciliation").